2022
Brentuximab-Induced Sensorimotor Polyneuropathy With Acquired Demyelinating Features Resembling Chronic Inflammatory Demyelinating Polyneuropathy
Zubair AS, Rethana M, Keung B. Brentuximab-Induced Sensorimotor Polyneuropathy With Acquired Demyelinating Features Resembling Chronic Inflammatory Demyelinating Polyneuropathy. Journal Of Clinical Neuromuscular Disease 2022, 23: 166-168. PMID: 35188920, DOI: 10.1097/cnd.0000000000000352.Peer-Reviewed Original ResearchConceptsChronic inflammatory demyelinating polyneuropathyInflammatory demyelinating polyneuropathyDemyelinating polyneuropathySensorimotor polyneuropathyDemyelinating featuresPolyneuropathy
2021
Brentuximab-induced sensorimotor polyneuropathy with acquired demyelinating features resembling chronic inflammatory demyelinating polyneuropathy (CIDP) (2084)
Zubair A, Rethana M, Keung B. Brentuximab-induced sensorimotor polyneuropathy with acquired demyelinating features resembling chronic inflammatory demyelinating polyneuropathy (CIDP) (2084). Neurology 2021, 96 DOI: 10.1212/wnl.96.15_supplement.2084.Peer-Reviewed Original ResearchChronic inflammatory demyelinating polyneuropathyInflammatory demyelinating polyneuropathyDemyelinating polyneuropathySensorimotor polyneuropathyPolyneuropathyBrentuximab